Papers

Peer-reviewed International journal
Oct, 2015

Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism.

Journal of clinical immunology
  • Yusuke Okuno
  • Akihiro Hoshino
  • Hideki Muramatsu
  • Nozomu Kawashima
  • Xinan Wang
  • Kenichi Yoshida
  • Taizo Wada
  • Masaharu Gunji
  • Tomoko Toma
  • Tamaki Kato
  • Yuichi Shiraishi
  • Atsuko Iwata
  • Toshinori Hori
  • Toshiyuki Kitoh
  • Kenichi Chiba
  • Hiroko Tanaka
  • Masashi Sanada
  • Yoshiyuki Takahashi
  • Shigeaki Nonoyama
  • Masafumi Ito
  • Satoru Miyano
  • Seishi Ogawa
  • Seiji Kojima
  • Hirokazu Kanegane
  • Display all

Volume
35
Number
7
First page
610
Last page
614
Language
English
Publishing type
Research paper (scientific journal)
DOI
10.1007/s10875-015-0202-0
Publisher
SPRINGER/PLENUM PUBLISHERS

Primary immunodeficiency disease (PID) is caused by mutations of more than two hundred immunity-related genes. In addition to the heterogeneity of the diseases, the atypical presentation of each disease caused by hypomorphic mutations or somatic mosaicism makes genetic diagnosis challenging. Next-generation sequencing tests all genes simultaneously and has proven its innovative efficacy in genomics. We describe a male PID patient without any family history of immunodeficiency. This patient suffered from recurrent infections from 1 year of age. Laboratory analysis showed hypogammaglobulinemia. T, B, and NK cells were present, but the T cell proliferative response decreased. Whole-exome sequencing analysis identified an IL2RG p.P58T missense mutation. CD8(+) and CD56(+) cells showed revertant somatic mosaicism to the wild-type allele. A late-onset and atypical presentation of the X-linked severe combined immunodeficiency (X-SCID) phenotype might be associated with revertant somatic mosaicism in T and NK cells. This patient is the seventh reported case of X-SCID with revertant somatic mosaicism. His classical clinical management did not result in a molecular diagnosis because of the atypical presentation. The coverage that is provided by whole-exome sequencing of most PID genes effectively excluded differential diagnoses other than X-SCID. As next-generation sequencing becomes available in clinical practice, it will enhance our knowledge of PID and rescue currently undiagnosed patients.

Link information
DOI
https://doi.org/10.1007/s10875-015-0202-0
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/26407811
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000363976500004&DestApp=WOS_CPL
ID information
  • DOI : 10.1007/s10875-015-0202-0
  • ISSN : 0271-9142
  • eISSN : 1573-2592
  • Pubmed ID : 26407811
  • Web of Science ID : WOS:000363976500004

Export
BibTeX RIS